Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q29398696)
Watch
English
Echinocandin antifungal drugs
scientific article (publication date: October 2003)
In more languages
edit
Statements
instance of
scholarly article
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Echinocandin antifungal drugs
(English)
1 reference
stated in
DOI.org query endpoint
reference URL
https://doi.org/10.1016%2FS0140-6736%2803%2914472-8
retrieved
14 April 2017
main subject
mycoproteins
1 reference
stated in
Europe PubMed Central
PubMed ID
14550704
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550704
retrieved
20 March 2024
author
David W. Denning
object named as
David W Denning
series ordinal
1
0 references
language of work or name
English
0 references
publication date
October 2003
1 reference
stated in
DOI.org query endpoint
reference URL
https://doi.org/10.1016%2FS0140-6736%2803%2914472-8
retrieved
14 April 2017
4 October 2003
1 reference
stated in
National Center for Biotechnology Information
PubMed ID
14550704
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14550704
retrieved
20 March 2024
number of pages
10
1 reference
based on heuristic
inferred from page(s)
full work available at URL
https://api.elsevier.com/content/article/PII:S0140673603144728?httpAccept=text/xml
1 reference
stated in
Crossref
DOI
10.1016/S0140-6736(03)14472-8
reference URL
https://api.crossref.org/works/10.1016/S0140-6736(03)14472-8
retrieved
20 March 2024
https://api.elsevier.com/content/article/PII:S0140673603144728?httpAccept=text/plain
1 reference
stated in
Crossref
DOI
10.1016/S0140-6736(03)14472-8
reference URL
https://api.crossref.org/works/10.1016/S0140-6736(03)14472-8
retrieved
20 March 2024
published in
The Lancet
1 reference
stated in
DOI.org query endpoint
reference URL
https://doi.org/10.1016%2FS0140-6736%2803%2914472-8
retrieved
14 April 2017
volume
362
1 reference
stated in
DOI.org query endpoint
reference URL
https://doi.org/10.1016%2FS0140-6736%2803%2914472-8
retrieved
14 April 2017
page(s)
1142-1151
1 reference
stated in
DOI.org query endpoint
reference URL
https://doi.org/10.1016%2FS0140-6736%2803%2914472-8
retrieved
14 April 2017
issue
9390
1 reference
stated in
DOI.org query endpoint
reference URL
https://doi.org/10.1016%2FS0140-6736%2803%2914472-8
retrieved
14 April 2017
cites work
Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postmortem analysis of invasive aspergillosis in a tertiary care hospital
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Invasive aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of opportunistic disease in an HIV-infected urban clinical cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disseminated Penicillium marneffei infection in southeast Asia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antifungal drug resistance in Aspergillus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metabolites of microorganisms. 143. Echinocandin B, a novel polypeptide-antibiotic from Aspergillus nidulans var. echinulatus: isolation and structural components
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pneumocandins from Zalerion arboricola. II. Modification of product spectrum by mutation and medium manipulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
WF11899A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glucan synthase inhibitors as antifungal agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organisms.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: production and biological activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fungal ß(1,3)-D-glucan synthesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular organization of the cell wall of Candida albicans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aspergillus fumigatus cell wall: composition and biosynthesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glucan synthase complex of Aspergillus fumigatus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta -1,3-glucan deposition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The yeast cell-wall salvage pathway
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of murine disseminated candidiasis with L-743,872
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of murine Candida krusei or Candida glabrata infection with L-743,872
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of caspofungin and amphotericin B for invasive candidiasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914472-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species
series ordinal
52
1 reference
stated in
Crossref
DOI
10.1016/S0140-6736(03)14472-8
reference URL
https://api.crossref.org/works/10.1016/S0140-6736(03)14472-8
retrieved
20 March 2024
Identifiers
DOI
10.1016/S0140-6736(03)14472-8
2 references
stated in
DOI.org query endpoint
reference URL
https://doi.org/10.1016%2FS0140-6736%2803%2914472-8
retrieved
14 April 2017
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
830273
OpenCitations bibliographic resource ID
830273
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
830273
PubMed ID
14550704
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
830273
ResearchGate publication ID
9056241
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit